These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33119142)

  • 1. Decision support for men with prostate cancer: Concordance between treatment choice and tumor risk.
    Filson CP; Hong F; Xiong N; Pozzar R; Halpenny B; Berry DL
    Cancer; 2021 Jan; 127(2):203-208. PubMed ID: 33119142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
    Berry DL; Hong F; Blonquist TM; Halpenny B; Xiong N; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M
    Urol Oncol; 2021 Aug; 39(8):493.e9-493.e15. PubMed ID: 33353864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
    Bosco JL; Halpenny B; Berry DL
    Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials.
    Trinh QD; Hong F; Halpenny B; Epstein M; Berry DL
    Urol Oncol; 2020 Mar; 38(3):78.e7-78.e13. PubMed ID: 31883873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial.
    Berry DL; Halpenny B; Hong F; Wolpin S; Lober WB; Russell KJ; Ellis WJ; Govindarajulu U; Bosco J; Davison BJ; Bennett G; Terris MK; Barsevick A; Lin DW; Yang CC; Swanson G
    Urol Oncol; 2013 Oct; 31(7):1012-21. PubMed ID: 22153756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.
    Wilson LS; Blonquist TM; Hong F; Halpenny B; Wolpin S; Chang P; Filson CP; Master VA; Sanda MG; Chien GW; Jones RA; Krupski TL; Berry DL
    BMC Med Inform Decis Mak; 2019 Jan; 19(1):6. PubMed ID: 30626400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer.
    Underhill ML; Hong F; Berry DL
    Health Qual Life Outcomes; 2014 Oct; 12():159. PubMed ID: 25344101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Patient Preference Measurement in Decision Aids Improve Decisional Conflict? A Randomized Trial in Men with Prostate Cancer.
    Shirk JD; Crespi CM; Saucedo JD; Lambrechts S; Dahan E; Kaplan R; Saigal C
    Patient; 2017 Dec; 10(6):785-798. PubMed ID: 28623628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.
    Berry DL; Hong F; Blonquist TM; Halpenny B; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M; Somayaji P
    J Urol; 2018 Jan; 199(1):89-97. PubMed ID: 28754540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer.
    Berry DL; Halpenny B; Wolpin S; Davison BJ; Ellis WJ; Lober WB; McReynolds J; Wulff J
    J Med Internet Res; 2010 Dec; 12(4):e67. PubMed ID: 21169159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer.
    Berry DL; Wang Q; Halpenny B; Hong F
    Patient Educ Couns; 2012 Aug; 88(2):262-7. PubMed ID: 22608696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
    Taylor KL; Hoffman RM; Davis KM; Luta G; Leimpeter A; Lobo T; Kelly SP; Shan J; Aaronson D; Tomko CA; Starosta AJ; Hagerman CJ; Van Den Eeden SK
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1240-50. PubMed ID: 27257092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care.
    Johnson DC; Mueller DE; Deal AM; Dunn MW; Smith AB; Woods ME; Wallen EM; Pruthi RS; Nielsen ME
    J Urol; 2016 Dec; 196(6):1640-1644. PubMed ID: 27346032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT.
    Diefenbach MA; Benedict C; Miller SM; Stanton AL; Ropka ME; Wen KY; Fleisher LG; Mohamed NE; Hall SJ
    Transl Behav Med; 2018 Nov; 8(6):876-886. PubMed ID: 29982747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
    Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
    BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.
    Xu J; Janisse J; Goodman M
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Cancer Patient Characteristics Associated With a Strong Preference to Preserve Sexual Function and Receipt of Active Surveillance.
    Broughman JR; Basak R; Nielsen ME; Reeve BB; Usinger DS; Spearman KC; Godley PA; Chen RC
    J Natl Cancer Inst; 2018 Apr; 110(4):420-425. PubMed ID: 29045679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Preference "Phenotypes" in Men With Prostate Cancer.
    Saigal C; Hollenbeck B; Penson D; Williams K; Kwan L; Saucedo J; Bergman J
    Urol Pract; 2024 Jul; 11(4):717-725. PubMed ID: 38899681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial.
    Thurtle D; Jenkins V; Freeman A; Pearson M; Recchia G; Tamer P; Leonard K; Pharoah P; Aning J; Madaan S; Goh C; Hilman S; McCracken S; Ilie PC; Lazarowicz H; Gnanapragasam V
    Eur Urol; 2021 Nov; 80(5):661-669. PubMed ID: 34493413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in treatment choices between prostate cancer patients using a decision aid and patients receiving care as usual: results from a randomized controlled trial.
    Lamers RED; Cuypers M; de Vries M; van de Poll-Franse LV; Bosch JLHR; Kil PJM
    World J Urol; 2021 Dec; 39(12):4327-4333. PubMed ID: 34272972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.